- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Significant Ownership of Logos Global Management LP
- Signature - Title
- /s/ Arsani William - Managing Partner
- Location
- San Francisco, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Logos Global Management LP.
Follow Filing Activity
Follow Logos Global Management LP and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of Logos Global Management LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NERV | Minerva Neurosciences, Inc. | Common Stock | 9.9% | $18,407,093 | 4,435,444 | Logos Global Management LP | 23 Dec 2025 | ||
| TENX | Tenax Therapeutics, Inc. | Common Stock | 9.9% | $7,995,000 | 615,000 | Logos Global Management LP | 27 Feb 2026 | ||
| PTNT | PALATIN TECHNOLOGIES INC | Common Stock | 9.9% | $1,458,493 | 142,292 | Logos Global Management LP | 06 Nov 2025 | ||
| AVTX | Avalo Therapeutics, Inc. | Common Stock | 5.6% | $23,104,300 | 1,285,000 | Logos Global Management LP | 26 Mar 2026 | ||
| ERAS | Erasca, Inc. | Common Stock | 4.8% | $29,648,000 | -$3,270,000 | 13,600,000 | -9.9% | Logos Global Management LP | 30 Sep 2025 |
| VSTM | Verastem, Inc. | Common Stock | 4.8% | $28,035,250 | -$2,207,500 | 3,175,000 | -7.3% | Logos Global Management LP | 30 Sep 2025 |
| OLMA | Olema Pharmaceuticals, Inc. | Common Stock | 4.7% | $16,172,730 | 3,208,875 | Logos Global Management LP | 18 Mar 2025 | ||
| IBIO | iBio, Inc. | Common Stock | 4.6% | $3,810,000 | -$1,270,000 | 1,500,000 | -25% | Logos Global Management LP | 31 Dec 2025 |
| DSGN | Design Therapeutics, Inc. | Common Stock | 4.4% | $16,322,350 | -$4,802,600 | 2,515,000 | -23% | Arsani William | 14 Nov 2025 |
| CBIO | CRESCENT BIOPHARMA, INC. | Ordinary Shares | 4.1% | $7,762,500 | 575,000 | Logos Global Management LP | 30 Jun 2025 | ||
| ARVN | ARVINAS, INC. | Common Stock ("Stock") | 3.4% | $21,300,000 | -$32,376,000 | 2,500,000 | -60% | Logos Global Management LP | 13 Oct 2025 |
| NXTC | NextCure, Inc. | Common Stock | 0% | $0 | 0 | Logos Global Management LP | 31 Dec 2024 | ||
| ELEV | Elevation Oncology, Inc. | Common Stock | 0% | $0 | 0 | Logos Global Management LP | 31 Dec 2024 | ||
| ANNX | Annexon, Inc. | Common Stock | 0% | $0 | -$17,028,000 | 0 | -100% | Logos Global Management LP | 30 Jun 2025 |
| PRTA | PROTHENA CORP PUBLIC LTD CO | Ordinary Shares | 0% | $0 | -$18,644,000 | 0 | -100% | Logos Global Management LP | 30 Jun 2025 |
Schedules 13D/G Reported by Logos Global Management LP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.